Session Details

Fibrinogen Factor XIII and Thrombin 1

Tuesday, 23 March 2004 11:15 -12:35

Co-Chair Michael W Mosesson The Blood Center of Southeastern WisconsinUnited States
Co-Chair Leonid Medved The American Red Cross Holland LaboratoryUnited States

Structure of the Complex Between Thrombin and the Central 'E' Region of Fibrin Established by X-Ray Analysis
  • Igor Pechik, The American Red Cross Holland Laboratory, United States
  • Structural Basis for Preferential Cleavage of Fibrinopeptide A from Fibrinogen by Thrombin as Revealed by X-Ray Analysis and Molecular Modelling of a Complex Between Thrombin and the Central 'E' Region of Fibrin
  • Leonid Medved, The American Red Cross Holland Laboratory, United States
  • Expression of Pathological Fibrinogen Mutants in the Yeast Pichia pastoris.
  • Amy Dear, Univeristy of Otago, Christchurch School of Medicine and Health Sciences, New Zealand
  • The Influence of Glycation on Fibrin Structure - A Mechanism for Altered Cardiovascular Risk in Diabetes
  • Emma J Dunn, Academic Unit of Molecular Vascular Medicine, University of Leeds., United Kingdom
  • Evidence that During Clot Formation Thrombin Behaves Like a Dimer that Enhances Fibrin Polymerization by Exosite 1-Dependent Non-Catalytic Bridging
  • Dr Michael W Mosesson, The Blood Center of Southeastern Wisconsin, United States
  • Interaction of Platelets with Liposome Preparations Containing Dodecapeptide Sequence from Fibrinogen
  • Dr Takako Nishiya, Fujirebio inc, Japan